


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T14:05:25Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12406434" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12406434</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>bmcid</setSpec>
        
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Infect Dis</journal-id><journal-id journal-id-type="iso-abbrev">BMC Infect Dis</journal-id><journal-id journal-id-type="pmc-domain-id">36</journal-id><journal-id journal-id-type="pmc-domain">bmcid</journal-id><journal-title-group><journal-title>BMC Infectious Diseases</journal-title></journal-title-group><issn pub-type="epub">1471-2334</issn><publisher><publisher-name>BMC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12406434</article-id><article-id pub-id-type="pmcid-ver">PMC12406434.1</article-id><article-id pub-id-type="pmcaid">12406434</article-id><article-id pub-id-type="pmcaiid">12406434</article-id><article-id pub-id-type="pmid">40898052</article-id><article-id pub-id-type="doi">10.1186/s12879-025-11490-5</article-id><article-id pub-id-type="publisher-id">11490</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Development of paper-based electrochemiluminescence test strips for pathogenic microorganisms</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Qin</surname><given-names initials="Y">Yao</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yuan</surname><given-names initials="S">Shichao</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wang</surname><given-names initials="X">Xihan</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="Q">Qinyi</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wu</surname><given-names initials="J">Jie</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Zhang</surname><given-names initials="H">Hongbin</given-names></name><address><email>zhangwater@hotmail.com</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Li</surname><given-names initials="L">Ling</given-names></name><address><email>liling@smu.edu.cn</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04k5rxe29</institution-id><institution-id institution-id-type="GRID">grid.410560.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1760 3078</institution-id><institution>Guangdong Medical University, </institution></institution-wrap>Dongguan, 523520 China </aff><aff id="Aff2"><label>2</label>General Hospital of Southern Theater Command of PLA, Guangzhou, 510010 China </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05v9jqt67</institution-id><institution-id institution-id-type="GRID">grid.20561.30</institution-id><institution-id institution-id-type="ISNI">0000 0000 9546 5767</institution-id><institution>South China Agricultural University, </institution></institution-wrap>Guangzhou, 510008 China </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01vjw4z39</institution-id><institution-id institution-id-type="GRID">grid.284723.8</institution-id><institution-id institution-id-type="ISNI">0000 0000 8877 7471</institution-id><institution>Southern Medical University, </institution></institution-wrap>Guangzhou, 510515 China </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04tms6279</institution-id><institution-id institution-id-type="GRID">grid.508326.a</institution-id><institution-id institution-id-type="ISNI">0000 0004 1754 9032</institution-id><institution>Guangdong Provincial Center for Disease and Prevention, </institution></institution-wrap>Guangzhou, 510515 China </aff></contrib-group><pub-date pub-type="epub"><day>3</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>25</volume><issue-id pub-id-type="pmc-issue-id">478176</issue-id><elocation-id>1097</elocation-id><history><date date-type="received"><day>25</day><month>4</month><year>2025</year></date><date date-type="accepted"><day>4</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>03</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 10:25:45.023"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="12879_2025_Article_11490.pdf"/><abstract id="Abs1"><sec><title>Background</title><p id="Par1">A novel paper-based electrochemiluminescence test strip (ECL-TS) for the detection of pathogenic microorganisms is developed by combining lateral flow immunochromatography(LFIC) with ECL.</p></sec><sec><title>Methods</title><p id="Par2">Based on the principle of double-antibody sandwich, monoclonal antibody 1 labeled with tris(bipyridine)ruthenium is fixed on the conjugate pad as the labeled antibody, and monoclonal antibody 2 is directly fixed on the detection pad as the capture antibody. The antibody is Made to flow to the detection region through LFIC and specifically bind to the capture antibody in the detection region. Cyclic voltammetry scanning is carried out at a speed of 0.1&#160;V/s in the detection region to obtain an ECL signal, which is then converted into the content of the virus in the sample to be tested.</p></sec><sec><title>Results</title><p id="Par3">Under the optimized conditions, the developed test strip could be detected within 5 min, with a minimum detection Limit of 7.96 pg/mL, a reproducibility deviation of 5.62%, a stability deviation of 6.34%, and a KAPPA value of 0.88, which was specific for the related viruses.</p></sec><sec><title>Conclusions</title><p id="Par4">The developed paper-based ECL-TS provides a portable, rapid and sensitive detection method. Taking the novel coronavirus (SARS-CoV-2) as an example, compared with the nucleic acid detection method, this method has the advantages of being rapid, accurate and low-cost. It is expected to be used as a point-of-care testing (POCT) tool in the detection of pathogenic microorganisms.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Electrochemiluminescence</kwd><kwd>Virus detection</kwd><kwd>Lateral flow immunochromatography</kwd><kwd>Point-of-care testing</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; BioMed Central Ltd., part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par12">In the development process of modern medical care and public health undertakings, the demand for rapid detection technologies has shown an explosive growth trend. In clinical medicine, rapid and accurate detection results are crucial for the early diagnosis of diseases, the timely formulation of treatment plans, and the dynamic monitoring of the progression of diseases [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. In the field of public health, when facing issues such as sudden infectious disease outbreaks and food safety hazards, rapid detection technologies serve as the key support for the prevention and control of epidemics and the early warning of risks. Against this backdrop, the research, development, and innovation of analytical instruments are advancing towards integration, miniaturization, and rapidity at an unprecedented pace [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>].</p><p id="Par13">Since scholars such as MANZ A [<xref ref-type="bibr" rid="CR5">5</xref>] first proposed the concept of micro total analysis systems(&#181;TAS), the &#8220;lab-on-a-chip&#8221; is gradually moving from scientific research laboratories to practical applications [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. Relying on micro-electromechanical system(MEMS) processes, the originally huge, complex and multifunctional analysis systems are ingeniously concentrated and integrated onto tiny chips. This has reduced the size of the instrument and equipment, simplified the experimental procedures, lowered costs, and improved the detection efficiency. Among them, the paper-based microfluidic device combines the capillary-driven characteristics of the lateral flow immunochromatography assay(LFIA) with new processing technologies such as printing and photolithography [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. It realizes qualitative analysis based on the specific recognition of antigen. The ECL detection technology based on paper has also been demonstrated in many reports [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. Paper possesses both rapid chromatographic efficiency and good biocompatibility, while the electrochemical sensor realizes the conversion of biological recognition and photoelectric signals based on the redox luminescence mechanism of Ru(bpy)&#8323;&#178;&#8314;/Ru(bpy)&#8323;&#179;&#8314; and others. [Ru(bpy)&#8322;(mcbpy-O-Su-ester)(PF&#8326;)&#8322;](Ru-NHS ester) is selected as the signal indicator due to its high ECL efficiency and strong stability. The succinimidyl ester group in its structure enables over 90% coupling efficiency with antibody amino groups, and the hydrophilic PF&#8326;&#8315; structure shows good compatibility with paper matrix, featuring no adsorption and low background [<xref ref-type="bibr" rid="CR12">12</xref>]. With a synthesis cost lower than that of rare earth nanoparticles, it outperforms traditional markers like luminol and quantum dots in comprehensive performance, making it suitable for POCT of pathogenic microorganisms [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. It can make up for the shortcomings of the paper-based LFIC detection technology in quantitative detection, thus achieving rapid and sensitive detection of target samples. In the application process of rapid detection, the electrochemical sensor platform demonstrates the advantages of high sensitivity, short response time, low background interference, low cost, and a wide detection range.</p><p id="Par14">Currently, research on the combined use of LFIC and ECL for SARS-CoV-2 detection remains unexplored. This study innovatively developed a paper-based ECL-TS. By adopting a double-antibody sandwich structure&#8212;tris(bipyridine)ruthenium-labeled antibody on the conjugate pad and capture antibody on the detection pad&#8212;it enables quantitative detection. Antigens migrate to form complexes, which are then excited by cyclic voltammetry to generate ECL signals. With a sensitivity of 7.96 pg/mL and a detection time within 5&#160;min, the technology features a wide linear range, low coefficient of variation, and high specificity. It provides a simple and efficient solution for POCT of pathogenic microorganisms and paves the way for the development of portable detection devices.</p></sec><sec id="Sec2"><title>Materials and methods</title><sec id="Sec3"><title>Materials</title><p id="Par15">SARS-CoV-2 antigens, Catalog number: ncov-PS-Ag6Purchased from Guangdong Fapon Biotech Co., Ltd.(China): and 2019-nCoV NP Antibody(7G9)Label antibodies, Catalog number: DA078 and 2019-nCoV NP Antibody(6G9)Capture antibodies, Catalog number: DA027. All were purchased from Suzhou Nearshore Protein Technology Co., Ltd; Tripropylamine(TPA), Dimethyl sulfoxide(DMSO)and TWEEN-20 purchased from Sigma Aldrich(USA), Elecsys Buffer purchased from Roche(Switzerland), Ru-NHS Ester(Ru(bpy)2(mcbpy-O-Su-ester)(PF<sub>6</sub>)<sub>2</sub>) Purchased from Shanghai Aladdin Biochemical Technology Co., Ltd.(China), Fiberglass RB45 and absorbent paper ABP-S270 were purchased from Huaiyuan Tongcheng Paper Products Co., Ltd.(China), UniSart CN95 membrane purchased from Sartorius(Germany); Whatman NO.1 purchased from Whatman(USA), Biodyne Cpurchased from PALL(USA), PT0.45&#160;&#956;m purchased from Cytiva(USA),5mL 7&#160;K MWCO Zeba&#8482;Rotate the desalting column purchased from Thermo(USA), Three-electrode Screen Printed Electrodes(SPEs) purchased from Zensor Technology Co., Ltd.(Taiwan, China), PBS Buffer(pH 7.4)prepared in the laboratory.</p></sec><sec id="Sec4"><title>Instruments</title><p id="Par16">RPEL-B type POCT The ECL detector was purchased from Xi&#8217;an Ruimai Analytical Instrument Co., Ltd.(China); HGS210 high-speed cutting machine and HGS510-1 desktop gold spray marking machine were purchased from Hangzhou Aotekun Technology Co., Ltd.(China); CNC strip cutting machine CTD300 purchased from Shanghai Jinbiao Biotechnology Co., Ltd. (China); Rotary pan mixers were purchased from Aquapro International Company LLC(USA); Electric Blower Drying Oven DHG-9240&#160;A Shanghai Yiheng Scientific Instrument Co., Ltd.(China); The Multiskan Go Microplate Reader was purchased from Thermo Scientific (USA).</p></sec><sec id="Sec5"><title>Methods</title><sec id="Sec6"><title>SARS-CoV-2 Ab1 ECL Preparation of biological probes</title><p id="Par17">The modification method of SARS-CoV-2 Ab1 using Ru-NHS ester is referred to relevant reports [<xref ref-type="bibr" rid="CR15">15</xref>&#8211;<xref ref-type="bibr" rid="CR17">17</xref>].The main experimental method was as follows: First, 5&#160;mg of Ru-NHS ester was allowed to reach room temperature. Then, 50 &#181;L of DMSO and 450 &#181;L of PBS were added, and the mixture was shaken to prepare a 10 mmol/L stock solution. Next, SARS-CoV-2 Ab1 was equilibrated to room temperature at a molar ratio of 50:1. In PBS, 500 &#181;L of antibody dilutions with a concentration of 20 &#181;mol/L and containing 1% BSA were prepared. The Ru-NHS ester stock solution was diluted to a working concentration of 1000 &#181;mol/L, and then thoroughly mixed with the antibody dilution. The mixture was wrapped in tin foil, placed in a rotary disc mixer, and reacted at room temperature with a rotation speed of 35 r/min for 12&#160;h. After full incubation, the ruthenium-labeled antibody solution was processed using a 5 mL 7&#160;K MWCO Zeba&#8482; spin desalting column to remove free Ru-NHS esters and other small-molecule impurities from the reaction products. Finally, Ru-NHS ester- labeled SARS-CoV-2 Ab1 was collected.</p></sec><sec id="Sec7"><title>Preparation of paper-based channels for LFIC</title><p id="Par18">The LFIC paper-based channel is composed of a 20-mm sample pad, a 10-mm binding pad, a 15-mm assay pad, and a 20-mm absorbent pad. The preparation process of the paper-based materials is as follows:</p><p id="Par19">Sample and Binding Pad Preparation: Pretreated glass fiber RB45 serves as the sample pad and binding pad. First, prepare the treatment solutions for the sample pad and binding pad. Mix 0.05&#160;M Tris-HCl (pH 7.4), 1% BSA, 0.5% sodium caseinate, 0.5% trehalose, 2% sucrose, 0.5&#160;mg/mL HBR, 0.5&#160;mg/mL heterophile antibody blocker, and 0.9% NaCl in PBS at pH 7.4. Then, evenly spray 24 mL of this treatment solution onto 250&#160;mm&#215;300&#160;mm sample pads and binding pads. After that, dry them overnight at 37&#160;&#176;C. Cut the sample pad into pieces of 6&#160;mm&#215;25&#160;mm for future use. Set the spraying parameters at 150 &#181;L/cm<sup>2</sup>. Use the HGS510-1 instrument to evenly spray Ru-NHS ester-labeled SARS-CoV-2 Ab1 onto the treated binding pad. Dry it overnight at 37&#160;&#176;C, cut the binding pad into 6&#160;mm&#215;10&#160;mm pieces, and dry it again for later use.</p><p id="Par20">Detection Pad Preparation: Cut the detection pad into discs with a diameter of 6&#160;mm and fix them in the same position as the circular detection area of the screen-printing electrode(SPE). Set the spraying parameters at 150 &#181;L/cm<sup>2</sup>. Use the HGS510-1 instrument to evenly spray SARS-CoV-2 Ab2 onto the detection pad, and dry it overnight at 37&#160;&#176;C.</p><p id="Par21">Assembly: Secure the absorbent pad to the tail of the chromatography strip to enable the absorption of excess reagent.</p></sec><sec id="Sec8"><title>Co-reactant system optimization</title><p id="Par22">ECL co-reactants, through electrochemical oxidation to generate radical intermediates, activate luminophores to produce photons, enabling signal amplification and reaction regulation [<xref ref-type="bibr" rid="CR18">18</xref>]. They serve as indispensable core components for signal enhancement and reaction modulation in ECL detection systems, mainly including amines(such as TPA, BDEA) [<xref ref-type="bibr" rid="CR19">19</xref>], oxalates, persulfates, and Elecsys buffer, etc [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>].</p><p id="Par23">To determine the optimal reaction system, a three-factor multi-level orthogonal experiment was designed to investigate the types, proportions, and addition sequences of co-reactants within the reaction system. A sample solution was prepared at a concentration of 2000 pg/mL, and the buffer was composed of co-reactants and PBS. Three common types of co-reactants for Ru - NHS esters were tested: the TPA group, the BDEA group, and the Elecsys buffer group. The ECL intensity of the reaction system was detected by comparing with a PBS blank control group and by mixing them in a volume ratio of 1:1. To detect the impact of different co-reactant ratios on the ECL intensity, under the optimal co-reactant conditions, the volume ratios of the sample solution to the co-reactant were set as 1:1, 2:1, 1:2, 2:3, and 4:1. To explore the conditions that would make the reaction system more sensitive and stable, the optimal ratio was pre-mixed in advance, and two groups were added during the reaction for testing purposes.</p></sec><sec id="Sec9"><title>Detection pads and immune response time optimization</title><p id="Par24">To ensure the detection sensitivity, the types and lengths of the paper chromatography detection pads were optimized. Whatman No. 1 filter paper, CN95 membrane, nylon transfer C membrane, and 0.45&#160;&#956;m nitrocellulose membrane were selected for the test. The length of the detection pad can influence the expansion speed of the sample. If the detection pad is too short, the normal immunochromatography process cannot be completed. On the other HANd, if it is too long, the sandwich complex formed by a pair of antibodies cannot be well retained in the detection area, which also leads to a reduction in the ECL signal. Therefore, three groups with lengths of 1.0&#160;cm, 1.5&#160;cm, and 2.5&#160;cm were set up to optimize the length of the detection pad. Based on the prepared paper-chip channel, the flow rate May be affected by the different physical and chemical properties of the selected paper Materials. In this study, the immune response time was optimized, and response time groups of 3&#160;min, 5&#160;min, 7&#160;min, and 9&#160;min were set.</p></sec><sec id="Sec10"><title>Paper-based ECL-TS for detection of SARS-CoV-2</title><p id="Par25">The SARS-CoV-2 antigen was allowed to reach room temperature. Then, 50 &#181;L of Elecsys buffer was added, and the volume was adjusted to 150 &#181;L with PBS (pH 7.4). The mixture was thoroughly blended and slowly dropped onto the sample area of the detection chip over a period of 5&#160;min. After the reaction was completed, the detection chip was placed into an ECL detector for detection using cyclic voltammetry. The scanning potential ranged from &#8722;&#8201;0.2&#160;V to +&#8201;1.0&#160;V, and the voltage of the photomultiplier tube was set at 800&#160;V. Figure&#160;<xref rid="Fig1" ref-type="fig">1</xref> presents the flowchart of the entire paper-based LFIC.</p><p id="Par26">
<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>Flow chart of paper-based LFIA figure Annotation: &#9312;Paper-based composition: <bold>a</bold>&#160;sample pad, <bold>b</bold>&#160;conjugation pad, <bold>c</bold>&#160;detection pad, <bold>d</bold>&#160;absorbent pad, <bold>e</bold>&#160;Detection Zone and <bold>f</bold> sample loading hole</p></caption><graphic id="MO1" position="float" orientation="portrait" xlink:href="12879_2025_11490_Fig1_HTML.jpg"/></fig>
</p></sec><sec id="Sec11"><title>Statistical analysis</title><p id="Par27">The standard deviation was calculated from the data of three replicate measurements. When the data followed a normal distribution, a Bonferroni-corrected t-test or analysis of variance(ANOVA) was conducted. Statistical significance was set at p-values less than the specified thresholds (*<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05; **<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01; ***<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001).</p><p id="Par28">Data processing and charting software GraphPad Prism 8.0(GraphPad Software, USA), Origin 9.1(OriginLab, USA), Microsoft Excel(Microsoft Office, USA), SPSS26.0(SPSS Inc., USA).</p></sec></sec></sec><sec id="Sec12"><title>Results</title><sec id="Sec13"><title>Optimization of ECL co-reactant system</title><p id="Par29">After assembling the LFIC test strips, the effects of different co-reactants were evaluated using a 2000 pg/mL SARS-CoV-2 sample dilution. As shown in Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>A, the mean ECL intensities of each group were as follows: 542&#8201;&#177;&#8201;29.02 for the PBS group, 2532&#8201;&#177;&#8201;72.89 for the TPA group, 2219&#8201;&#177;&#8201;57.05 for the BDEA group, and 3793&#8201;&#177;&#8201;12.22 for the Elecsys buffer group (<italic toggle="yes">n</italic>&#8201;=&#8201;3, with three parallel measurements). In the ECL system, TPA and BDEA are commonly used as ECL co-reactants due to their strong reducing properties, which can rapidly transfer electrons to the luminophore to promote the formation of excited states and enhance the detection accuracy and signal intensity [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. Elecsys Buffer is composed of special surfactants, phosphate buffer, TPA, detergents, and preservatives. The phosphate buffer stabilizes the pH to create a suitable environment for antigen-antibody reactions; surfactants remove unreacted antigens or antibodies; and TPA participates in chemiluminescence to enable precise determination of ultratrace substances [<xref ref-type="bibr" rid="CR24">24</xref>]. Therefore, Elecsys buffer was identified as the optimal co-reactant for Ru-NHS ester.</p><p id="Par30">When the concentration ratios of reactants added to the sample dilution were set at 1:1, 1:2, 2:1, 2:3, and 4:1, as shown in Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>B, the mean ECL intensities of each group were 3473&#8201;&#177;&#8201;81.12, 2742&#8201;&#177;&#8201;109.32, 4488&#8201;&#177;&#8201;78.64, 2158&#8201;&#177;&#8201;110.50, and 1523&#8201;&#177;&#8201;72.11, respectively (<italic toggle="yes">n</italic>&#8201;=&#8201;3). The ECL intensity of the 2:1 ratio group was significantly higher than other groups (one-way ANOVA, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01) Thus, the optimal ratio of co-reactants was determined to be 2:1.</p><p id="Par31">As presented in Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>C, the ECL intensities of the two test groups were 2310&#8201;&#177;&#8201;65.11 and 4428&#8201;&#177;&#8201;104.70, respectively (<italic toggle="yes">n</italic>&#8201;=&#8201;3), and the premixed group exhibited a 1.92-fold higher intensity than the non-premixed group (independent t-test, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05), indicating superior sensitivity.</p><p id="Par32">In conclusion, Elecsys buffer was selected as the co-reactant. Premixing Ru-NHS ester with the buffer at a volume ratio of 2:1 before the test yielded the highest ECL performance.</p><p id="Par33">
<fig id="Fig2" position="float" orientation="portrait"><label>Fig. 2</label><caption><p>Effect of different co-reactant systems on ECL intensity configure SARS-Cov-2 with a concentration of 2000 pg/mL. <bold>A&#160;</bold>Response values of ECL intensities for different co-reactants. <bold>B&#160;</bold>Response values of Elecsys buffer at different volume ratios to the ECL intensity of the sample. <bold>C&#160;</bold>Co-reactant addition order response to ECL. p&#8201;&lt;&#8201;0.05 was considered significant(*p&#8201;&lt;&#8201;0.05, was considered significant, **p&#8201;&lt;&#8201;0.01, was considered very significant and ***p&#8201;&lt;&#8201;0.001, was considered extremely significant.); <bold>A</bold> p&#8201;&lt;&#8201;0.01, <bold>B</bold> p&#8201;&lt;&#8201;0.01, and <bold>C</bold> p&#8201;&lt;&#8201;0.001, all of which were less than 0.01, were considered significant</p></caption><graphic id="MO2" position="float" orientation="portrait" xlink:href="12879_2025_11490_Fig2_HTML.jpg"/></fig>
</p></sec><sec id="Sec14"><title>Detection conditions and immune response time optimized</title><p id="Par34">The detection pad is the core component of ECL detection. It needs to have adsorption properties for target molecules (antibodies) to capture substances to be detected. During the chromatographic immunoassay process, it should also possess hydrophilicity and uniform porosity [<xref ref-type="bibr" rid="CR25">25</xref>]. Meanwhile, it must meet the requirements of electrical conductivity and luminescence for ECL detection. Whatman No. 1 filter paper belongs to non-uniform porous materials, which are traditionally used for precipitation separation, and the chromatography effect is general [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. Nitrocellulose membrane can maintain protein adsorption for a long time through hydrophobic interaction mediation and electrostatic force, but it has poor electrical conductivity and is not suitable for electrochemical detection [<xref ref-type="bibr" rid="CR28">28</xref>].The nylon transfer C-membrane has sufficient carboxyl groups on its surface for protein adsorption, and its hydrophilicity facilitates sample immersion [<xref ref-type="bibr" rid="CR29">29</xref>]. This study innovatively uses a CN95 membrane, which is essentially a nitrocellulose membrane with a backing. It has a pore size of approximately 15 microns, enabling faster chromatography speed, especially suitable for lateral flow assays [<xref ref-type="bibr" rid="CR30">30</xref>]. Meanwhile, the nitro groups on its surface exhibit strong electron-withdrawing ability, which can meet the requirements of ECL detection.</p><p id="Par35">A 200 pg/mL sample solution was prepared, with one-third of the dilution being Elecsys buffer and the remainder supplemented with PBS for testing. As shown in Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>A, the mean luminous intensities of the CN95 membrane, nylon transfer C membrane, 0.45&#160;&#956;m nitrocellulose membrane, and Whatman No. 1 filter paper were 3304&#8201;&#177;&#8201;50.66, 1530&#8201;&#177;&#8201;10.54, 1200&#8201;&#177;&#8201;35.56, and 2239&#8201;&#177;&#8201;54.03 respectively (<italic toggle="yes">n</italic>&#8201;=&#8201;3). The CN95 detection pad exhibited the highest average luminous intensity, making it the most suitable material for the detection pad of the detection chip.</p><p id="Par36">Using the CN95 membrane with optimal performance as the detection pad Material, it was cut into lengths of 1.0&#160;cm, 1.5&#160;cm, and 2.5&#160;cm respectively, and the ECL intensity of the 200 pg/mL sample solution was detected. The results indicated that the mean ECL intensities of the three groups were 1060&#8201;&#177;&#8201;77.35, 2477&#8201;&#177;&#8201;22.05, and 1413&#8201;&#177;&#8201;41.04 respectively(<italic toggle="yes">n</italic>&#8201;=&#8201;3). As presented in Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>B, the 1.5&#160;cm group had the highest mean ECL intensity, so 1.5&#160;cm was chosen as the length of the detection pad.</p><p id="Par37">In this study, the ECL signals of a 20,000 pg/mL sample solution were detected at reaction times of 3, 5, 7, and 9&#160;min respectively. The results are shown in Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>C, and the mean ECL intensity were 3104&#8201;&#177;&#8201;89.85, 6633&#8201;&#177;&#8201;44.50, 5164&#8201;&#177;&#8201;237.02, and 2656&#8201;&#177;&#8201;66.94 respectively(<italic toggle="yes">n</italic>&#8201;=&#8201;3). The results demonstrated that the ECL intensity was highest when the reaction time was 5&#160;min. Therefore, 5&#160;min was selected as the optimal reaction time for the paper-based ECL-TS.</p><p id="Par38">
<fig id="Fig3" position="float" orientation="portrait"><label>Fig. 3</label><caption><p>The type of paper chromatography test pad and the length of the test pad correspond to the ECL intensity&#160;<bold>A&#160;</bold>The effect of different detection pads on the ECL intensity at a concentration of 200 pg/mL of SARS-CoV-2; <bold>B&#160;</bold>The effect of different lengths of CN95 detection pads on the ECL intensity at a concentration of 100 pg/mL SARS-CoV-2; <bold>C&#160;</bold>The Effect of different immune response times on the ECL intensity at a concentration of 20 ng/mL SARS-CoV-2. <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05 was considered significant. <bold>A</bold><italic toggle="yes"> p</italic>&#8201;&lt;&#8201;0.001, <bold>B</bold>
<italic toggle="yes"> p</italic>&#8201;&lt;&#8201;0.001, and <bold>C</bold>
<italic toggle="yes"> p</italic>&#8201;&lt;&#8201;0.01</p></caption><graphic id="MO3" position="float" orientation="portrait" xlink:href="12879_2025_11490_Fig3_HTML.jpg"/></fig>
</p></sec><sec id="Sec15"><title>Optimization of the ratio of capture and labeled antibody concentrations</title><p id="Par39">To ensure the sensitivity and specificity of detection and avoid the hook effect [<xref ref-type="bibr" rid="CR31">31</xref>], in the early stage, antibody pairs against SARS-CoV-2 were initially screened using the checkerboard method [<xref ref-type="bibr" rid="CR32">32</xref>]. The optimal antibody pair was selected, and the best ratio in ELISA testing was referenced. Four reaction groups were established with concentration ratios of capture antibody to labeled antibody as 2&#160;mg/mL:2&#160;mg/mL, 1&#160;mg/mL:2&#160;mg/mL, 2&#160;mg/mL:1&#160;mg/mL, and 1&#160;mg/mL:1&#160;mg/mL, with triplicate measurements for each group. As shown in Fig.&#160;<xref rid="Fig4" ref-type="fig">4</xref>, the ECL intensities were 3738&#8201;&#177;&#8201;105.08, 5068&#8201;&#177;&#8201;139.89, 458&#8201;&#177;&#8201;21.38, and 589&#8201;&#177;&#8201;15.63, respectively. The results showed that a stronger ECL signal was generated when the ratio of capture antibody to labeled antibody was 1&#160;mg/mL:2&#160;mg/mL, which was determined as the optimal ratio for the capture and labeled antibodies, as illustrated in Fig.&#160;<xref rid="Fig4" ref-type="fig">4</xref>.</p><p id="Par40">
<fig id="Fig4" position="float" orientation="portrait"><label>Fig. 4</label><caption><p>Different concentrations of captured and labeled antibodies correspond to ECL response values the concentration of SARS-Cov-2 was 5000 pg/mL, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05 was considered significant. <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01, which was significantly different</p></caption><graphic id="MO4" position="float" orientation="portrait" xlink:href="12879_2025_11490_Fig4_HTML.jpg"/></fig>
</p></sec><sec id="Sec16"><title>Performance analysis of paper-based ECL-TS</title><p id="Par41">To explore the minimum detection limit of the paper-based ECL-TS, ten samples with a SARS-CoV-2 concentration of 0 were detected. The measured values were used to calculate based on the signal-to-noise ratio (S/N) of 3. By substituting into the standard curve formula, the minimum detection Limit was determined to be 7.96 pg/mL.</p><p id="Par42">To investigate the relationship between the ECL intensity of the paper chips and the viral load, we employed the paper - based ECL-TS to detect SARS-CoV-2 at concentrations of 7.96, 20, 200, 2000, 5000, and 20,000 pg/mL. It was found that the ECL signal gradually increased as the antigen concentration rose. As depicted in Fig.&#160;<xref rid="Fig5" ref-type="fig">5</xref>, there is a favorable Linear relationship between the ECL intensity and the logarithm of the antigen concentration in the range of 7.96&#8211;20,000 pg/mL. The linear fitting equation is I<sub>ECL</sub>=1317.4lg C<sub>SARS-CoV-2</sub>+481.35, with a correlation coefficient <italic toggle="yes">R</italic><sup>2</sup>&#8201;=&#8201;0.9922. This indicates that the detection of SARS-CoV-2 by this method is accurate and reliable.</p><p id="Par43">
<fig id="Fig5" position="float" orientation="portrait"><label>Fig. 5</label><caption><p>Linear relationship between SARS-CoV-2 concentrations and ECL intensity at 7.96, 20, 200, 2000, and 20,000 pg/mL</p></caption><graphic id="MO5" position="float" orientation="portrait" xlink:href="12879_2025_11490_Fig5_HTML.jpg"/></fig>
</p></sec><sec id="Sec17"><title>Performance verification of paper-based ECL-TS</title><sec id="Sec18"><title>Spike-recovery rate</title><p id="Par44">Samples with an initial concentration of 2000 pg/mL were prepared. Subsequently, samples of three distinct concentrations were separately introduced to conduct spike - recovery rate tests. The findings of these tests are presented in the Table&#160;<xref rid="Tab1" ref-type="table">1</xref>. The spike-recovery rates obtained from the experiments were within the ranges of 95.02%&#8722;104.53%, 99.4% &#8722;103.65%, and 95.85%&#8722;101.13% respectively. The calculated average recovery rate reached 99.49%. These results strongly suggest that the proposed method exhibits a high degree of accuracy and reliability.</p><p id="Par45">
<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Test results of Spike - recovery for ECL - TS</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Sample</th><th align="left" colspan="1" rowspan="1">Original sample concentration(pg/mL)</th><th align="left" colspan="1" rowspan="1">Addition amount(pg/mL)</th><th align="left" colspan="1" rowspan="1">Measured concentration(pg/mL)</th><th align="left" colspan="1" rowspan="1">Recovery rate(%)</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">2000</td><td align="left" colspan="1" rowspan="1">500</td><td align="left" colspan="1" rowspan="1">2475.13</td><td align="left" colspan="1" rowspan="1">95.02</td></tr><tr><td align="left" colspan="1" rowspan="1">2</td><td align="left" colspan="1" rowspan="1">2000</td><td align="left" colspan="1" rowspan="1">500</td><td align="left" colspan="1" rowspan="1">2522.64</td><td align="left" colspan="1" rowspan="1">104.53</td></tr><tr><td align="left" colspan="1" rowspan="1">3</td><td align="left" colspan="1" rowspan="1">2000</td><td align="left" colspan="1" rowspan="1">500</td><td align="left" colspan="1" rowspan="1">2511.89</td><td align="left" colspan="1" rowspan="1">96.76</td></tr><tr><td align="left" colspan="1" rowspan="1">4</td><td align="left" colspan="1" rowspan="1">2000</td><td align="left" colspan="1" rowspan="1">2000</td><td align="left" colspan="1" rowspan="1">3988.00</td><td align="left" colspan="1" rowspan="1">99.40</td></tr><tr><td align="left" colspan="1" rowspan="1">5</td><td align="left" colspan="1" rowspan="1">2000</td><td align="left" colspan="1" rowspan="1">2000</td><td align="left" colspan="1" rowspan="1">4073.09</td><td align="left" colspan="1" rowspan="1">103.65</td></tr><tr><td align="left" colspan="1" rowspan="1">6</td><td align="left" colspan="1" rowspan="1">2000</td><td align="left" colspan="1" rowspan="1">2000</td><td align="left" colspan="1" rowspan="1">4024.93</td><td align="left" colspan="1" rowspan="1">101.25</td></tr><tr><td align="left" colspan="1" rowspan="1">7</td><td align="left" colspan="1" rowspan="1">2000</td><td align="left" colspan="1" rowspan="1">5000</td><td align="left" colspan="1" rowspan="1">6792.29</td><td align="left" colspan="1" rowspan="1">95.85</td></tr><tr><td align="left" colspan="1" rowspan="1">8</td><td align="left" colspan="1" rowspan="1">2000</td><td align="left" colspan="1" rowspan="1">5000</td><td align="left" colspan="1" rowspan="1">6891.94</td><td align="left" colspan="1" rowspan="1">97.84</td></tr><tr><td align="left" colspan="1" rowspan="1">9</td><td align="left" colspan="1" rowspan="1">2000</td><td align="left" colspan="1" rowspan="1">5000</td><td align="left" colspan="1" rowspan="1">7155.19</td><td align="left" colspan="1" rowspan="1">101.13</td></tr></tbody></table></table-wrap>
</p></sec><sec id="Sec19"><title>Specificity</title><p id="Par46">To evaluate the specificity of the paper-based ECL-TS for SARS-CoV-2 antigens, the experiment was designed with the following groups: a PBS blank control group, positive control groups for parainfluenza virus type 2, respiratory syncytial virus type B, adenovirus type 1, influenza A H3N2, and influenza B Victoria, as well as a 20 pg/mL SARS-CoV-2 positive control group. Test samples were pretreated following the SARS-CoV-2 preparation protocol. For the actual situation of this study, the specificity of the detection system was defined by its tolerance to non-target viruses, and the &#8220;critical value&#8221; was determined to be 1031.8 through experiments. This critical value indicates the presence of SARS-CoV-2, where differences in ECL response below the established threshold are classified as negative, and those exceeding it are classified as positive [<xref ref-type="bibr" rid="CR33">33</xref>]. As shown in Fig.&#160;<xref rid="Fig6" ref-type="fig">6</xref>, the positive control group exhibited obvious changes in ECL response, while no significant changes were detected in each interfering group (with values below the threshold of 1031.8). The results demonstrate that the paper-based ECL-TS proposed in this study has no cross-reactivity with multiple respiratory viruses and shows selectivity and specificity for SARS-CoV-2 detection.</p><p id="Par47">
<fig id="Fig6" position="float" orientation="portrait"><label>Fig. 6</label><caption><p>Specificity detection of paper-based ECL-TS</p></caption><graphic id="MO6" position="float" orientation="portrait" xlink:href="12879_2025_11490_Fig6_HTML.jpg"/></fig>
</p></sec><sec id="Sec20"><title>Repeatability</title><p id="Par48">To validate the detection repeatability of the paper-based ECL-TS, ten paper-based ECL-TSs at two different concentrations were prepared at distinct time points. ECL detection was then performed using SARS-CoV-2 samples at concentrations of 500 pg/mL and 5000 pg/mL, with results presented in Table&#160;<xref rid="Tab2" ref-type="table">2</xref>. The standard deviations (<italic toggle="yes">SD</italic>) of the low-concentration and high-concentration groups were 181.7 pg/mL and 242.8 pg/mL, respectively, both satisfying the criterion of <italic toggle="yes">SD</italic>&#8201;&#8804;&#8201;mean &#215; 10%. The relative standard deviations (<italic toggle="yes">RSDs</italic>) were 4.6% and 4.8%, respectively, both below 5%. These findings indicate that the paper-based ECL-TS exhibits consistent detection results across a broad concentration range (500&#8211;5000 pg/mL), reducing the risk of missed detection in patients with low viral loads and enhancing the detection rate in those with high viral loads, thereby demonstrating favorable methodological repeatability.</p><p id="Par49">
<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Repeatability of paper-based ECL-TS</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Concentration</th><th align="left" colspan="1" rowspan="1">Mean</th><th align="left" colspan="1" rowspan="1">SD</th><th align="left" colspan="1" rowspan="1">RSD</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">5000 pg/mL</td><td align="left" colspan="1" rowspan="1">5066.1</td><td align="left" colspan="1" rowspan="1">242.8</td><td align="left" colspan="1" rowspan="1">4.8%</td></tr><tr><td align="left" colspan="1" rowspan="1">500 pg/mL</td><td align="left" colspan="1" rowspan="1">3992.7</td><td align="left" colspan="1" rowspan="1">181.7</td><td align="left" colspan="1" rowspan="1">4.6%</td></tr></tbody></table></table-wrap>
</p></sec><sec id="Sec21"><title>Stability</title><p id="Par50">To verify the detection stability of the paper-based ECL-TS, three sets of paper-based ECL-TS (10 strips per set) were prepared at different time points (30 days apart). ECL detection was performed using a 200 pg/mL SARS-CoV-2 sample. The stability of the test strips was validated by evaluating the current response changes after 30 and 60 days of storage, with an ECL variation of less than 10% considered acceptable, as shown in Table&#160;<xref rid="Tab3" ref-type="table">3</xref>. The average ECL intensities of the three groups were 3275.6, 3209.2, and 3023.3, with a standard deviation of 200.53 and a relative standard deviation of 6.34%. The decrease in ECL intensity May be attributed to Light-induced decomposition of ruthenium complexes and increased channel resistance due to moisture absorption in the paper Matrix. These results indicate that the paper-based ECL-TS exhibits good stability within 60 days.</p><p id="Par51">
<table-wrap id="Tab3" position="float" orientation="portrait"><label>Table 3</label><caption><p>Stability of paper-based ECL-TS</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Concentration</th><th align="left" colspan="1" rowspan="1">ECL intensity</th><th align="left" colspan="1" rowspan="1">Mean for each group</th><th align="left" colspan="1" rowspan="1">SD</th><th align="left" colspan="1" rowspan="1">RSD</th></tr></thead><tbody><tr><td align="left" rowspan="3" colspan="1">200 pg/mL</td><td align="left" colspan="1" rowspan="1">3275.6</td><td align="left" rowspan="3" colspan="1">3169.4</td><td align="left" rowspan="3" colspan="1">200.53</td><td align="left" rowspan="3" colspan="1">6.34%</td></tr><tr><td align="left" colspan="1" rowspan="1">3209.2</td></tr><tr><td align="left" colspan="1" rowspan="1">3023.3</td></tr></tbody></table></table-wrap>
</p></sec><sec id="Sec22"><title>Positive coincidence rate analysis</title><p id="Par52">In this study, 85 nasal swab samples were collected from SARS-CoV-2 patients, among which 45 were confirmed positive and 40 negative by nucleic acid testing. Based on the results of nucleic acid detection, paper-based ECL-TS was used for comparison. The results are presented in Table&#160;<xref rid="Tab4" ref-type="table">4</xref>: there were 43 true positives, 3 false positives, 2 false negatives, and 37 true negatives. According to the formulas: sensitivity&#8201;=&#8201;a/(a&#8201;+&#8201;c)&#215;100%, specificity&#8201;=&#8201;d/(b&#8201;+&#8201;d)&#215;100%, and total coincidence rate=(a&#8201;+&#8201;d)/(a&#8201;+&#8201;b&#8201;+&#8201;c&#8201;+&#8201;d)&#215;100%, the sensitivity was calculated to be 95.56%, the specificity was 92.5%, and the total coincidence rate was 94.12%. The KAPPA value was calculated to be 0.88 according to reference [<xref ref-type="bibr" rid="CR34">34</xref>]. The excellent repeatability indicates that the paper - based ECL-TS shows a high level of consistency with the nucleic acid test results, suggesting that the paper-based ECL - TS has the capability to detect SARS-CoV-2 effectively.</p><p id="Par53">
<table-wrap id="Tab4" position="float" orientation="portrait"><label>Table 4</label><caption><p>Four-grid table for qualitative analysis of paper-based ECL-TS and PCR</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1">Paper-based ECL-TS</th><th align="left" colspan="2" rowspan="1">PCR</th><th align="left" rowspan="2" colspan="1">Total</th></tr><tr><th align="left" colspan="1" rowspan="1">Positive(+)</th><th align="left" colspan="1" rowspan="1">Negative(-)</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Positive(+)</td><td align="left" colspan="1" rowspan="1">43</td><td align="left" colspan="1" rowspan="1">3</td><td align="left" colspan="1" rowspan="1">46</td></tr><tr><td align="left" colspan="1" rowspan="1">Negative(-)</td><td align="left" colspan="1" rowspan="1">2</td><td align="left" colspan="1" rowspan="1">37</td><td align="left" colspan="1" rowspan="1">39</td></tr><tr><td align="left" colspan="1" rowspan="1">Total</td><td align="left" colspan="1" rowspan="1">45</td><td align="left" colspan="1" rowspan="1">40</td><td align="left" colspan="1" rowspan="1">85</td></tr></tbody></table></table-wrap>
</p></sec></sec></sec><sec id="Sec23"><title>Discussion</title><p id="Par54">Early detection continues to stand as an indispensable linchpin in tracking the virus&#8217;s evolutionary course and the diverse and complex stages of the pandemic. Consequently, it assumes a pivotal and instrumental role in devising and implementing large - scale strategies aimed at mitigating the spread of the disease [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>].Given that traditional testing is often restricted to specific populations and regions, it is imperative to develop more sensitive, rapid, and convenient detection methods. Moreover, there are stringent requirements for the sensitivity and accuracy of COVID-19 antigen test strips [<xref ref-type="bibr" rid="CR37">37</xref>].In the LFIA reagents in China, the antigen - labeling technologies mainly consist of four types: colloidal gold labeling, nano - fluorescence labeling based on rare - earth materials, quantum - dot fluorescence labeling, and up - conversion fluorescence labeling. These technologies can further break through the limitations of traditional LFIA technology, which relies on visual inspection of detection lines and control lines for qualitative result determination, enabling the detection results to develop in the direction of higher sensitivity and intelligence [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref>].However, the time required for immunodetection subsequent to the labeling process exceeds 15&#160;min [<xref ref-type="bibr" rid="CR40">40</xref>].It fails to meet the time demands of on - site rapid inspection. In this study, triplet pyridineruthenium was pre-combined with SARS-CoV-2 Ab1, and then immobilized with SARS-CoV-2 Ab2 on the paper - based ECL-TS. This enables direct application for on - site rapid detection in the subsequent stage, significantly enhancing the detection efficiency.</p><p id="Par55">Other burgeoning biosensors, exemplified by nanobiotechnology and synthetic biology, also serve as highly essential auxiliary detection technologies. These are crucial for fulfilling the requirements of large-scale and cost-effective antigen detection [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR42">42</xref>].Microfluidic technology and electrochemical chips are designed to integrate the detection of SARS-CoV-2 and its variants, enabling rapid screening. With a short detection time, they can more effectively meet the requirements of POCT [<xref ref-type="bibr" rid="CR43">43</xref>&#8211;<xref ref-type="bibr" rid="CR45">45</xref>];The integration of electrochemical and immunobiosensing technologies for the purpose of facilitating the detection of SARS-CoV-2 is continuously surmounting the limitations of traditional detection techniques [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>].</p><p id="Par56">In this study, the paper-based microfluidic channels prepared were linear three-channel structures, which were clearly demarcated into four distinct areas: the sampling area, the binding area, the detection area, and the water absorption area. An electrochemiluminescent biological probe of SARS-CoV-2 Ab1 antibody labeled with triphipyridine ruthenium was employed and immobilized in the paper - based binding region. Meanwhile, the SARS-CoV-2 Ab2 was fixed in the paper-based material detection area through gold-spraying technology, thus forming a stable sandwich - like complex. By integrating paper chromatography and screen-printed electrode(SPE), a simple and low-cost electrochemical detection platform was fabricated. This platform enables experimenters to operate without prior training. Merely by injecting a single sample, results can be obtained within a few min. It features easy operation and rapid detection, effectively making up for the drawbacks of traditional nucleic acid detection methods, such as high cost, long time-consumption, complexity, and cumbersomeness. It offers a fast, simple, feasible, and reliable new approach for the detection of SARS-CoV-2. This platform can serve as a novel sensor platform for on-site testing in remote countries or regions, holding significant public health implications for large-scale infection screening. Simultaneously, it also presents a new concept for the on-site rapid detection of other epidemic infectious diseases and provides a new detection concept for the control of potential future infectious disease outbreaks.</p><p id="Par57">Limitations: This study is exclusively applicable to single - analysis scenarios, and the obtained results should be interpreted within a specific time-frame. The accuracy of the results may be lower compared to laboratory-based tests. Additionally, the tested samples pose challenges in terms of storage. The reproducibility of the experiment may exhibit variability among different batches. It is imperative to continuously optimize the materials and experimental conditions of each component to enhance the accuracy and reliability of this detection technology.</p><p id="Par58">The research group plans to further collect both clinical negative and positive samples for real-sample testing. This effort aims to lay a solid foundation for the clinical application and commercialization of the test strips. Moreover, the group intends to extend the application of this method to the detection of viruses such as influenza A and influenza B.</p></sec><sec id="Sec24"><title>Conclusions</title><p id="Par59">The paper-based ECL-TS developed in this study provides a portable, rapid (detection within 5&#160;min), and highly sensitive method for pathogenic microorganisms. Taking SARS-CoV-2 as the research subject, this design is easy to operate, cost-effective, and environmentally friendly. The method has a low detection Limit of 7.96 pg/mL, along with a repeatability (RSD) of 5.62%, a stability (RSD) of 6.34%, and excellent specificity. It demonstrates a high consistency with traditional nucleic acid detection (KAPPA value&#8201;=&#8201;0.88, total coincidence rate&#8201;=&#8201;94.12%), making it suitable as a clinical auxiliary diagnostic tool. Furthermore, it has advanced the development of rapid detection equipment for epidemic infectious diseases and provided novel technologies for epidemiological investigation and virus diagnosis of pathogenic microorganisms.&#160;</p><sec id="Sec25"><title>Patents</title><p id="Par60">Name: A paper-based electrochemiluminescent test strip for detecting novel coronavirus antigens and its preparation method and application.&#160;NO.202411458401.1.</p></sec></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>ECL-TS</term><def><p id="Par5">Electrochemiluminescent test strip</p></def></def-item><def-item><term>ECL</term><def><p id="Par6">Electrochemiluminescence</p></def></def-item><def-item><term>TPA</term><def><p id="Par7">Tripropylamine</p></def></def-item><def-item><term>BDEA</term><def><p id="Par8">N-Butyldiethanolamine</p></def></def-item><def-item><term>NHS</term><def><p id="Par9">N-Hydroxy succinimide</p></def></def-item><def-item><term>EDC</term><def><p id="Par10">1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydro</p></def></def-item><def-item><term>PBS</term><def><p id="Par11">Phosphate buffered saline</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher&#8217;s Note</bold></p><p>The statements, opinions and data contained in all publications are 420 solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI 421 and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, 422 methods, instructions or products referred to in the content.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The research was supported by the Basic Medical Research Department of the Southern Theater General Hospital of the Chinese People&#8217;s Liberation Army and researchers.</p></ack><notes notes-type="author-contribution"><title>Authors&#8217; contributions</title><p>Author Contributions: YQ and SY: Methodology, Validation, Writing original draft. X W: Investigation, Data curation. QZ: Data curation, Formal analysis. JW: Formal analysis, Resources, Software. LL: Methodology, Supervision, Writing review and editing. HZ: Conceptualization, Methodology, Writing review and editing, Supervision.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This research was funded by the projects in key areas of Guangdong Province, grant number 2022B1111020006.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>The data are provided in the manuscript or supplementary information files.</p></notes><notes><title>Declarations</title><notes id="FPar1" notes-type="COI-statement"><title>Competing interests</title><p id="Par61">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Florkowski</surname><given-names>C</given-names></name><name name-style="western"><surname>Don-Wauchope</surname><given-names>A</given-names></name><name name-style="western"><surname>Gimenez</surname><given-names>N</given-names></name><etal/></person-group><article-title>Point-of-care testing (POCT) and evidence-based laboratory medicine (EBLM) - does it leverage any advantage in clinical decision making?</article-title><source>Crit Rev Clin Lab Sci</source><year>2017</year><volume>54</volume><issue>7&#8211;8</issue><fpage>471</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">29169287</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/10408363.2017.1399336</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Florkowski C, Don-Wauchope A, Gimenez N, et al. Point-of-care testing (POCT) and evidence-based laboratory medicine (EBLM) - does it leverage any advantage in clinical decision making? Crit Rev Clin Lab Sci. 2017;54(7&#8211;8):471&#8211;94.<pub-id pub-id-type="pmid">29169287</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/10408363.2017.1399336</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>P</given-names></name><name name-style="western"><surname>Kricka</surname><given-names>LJ</given-names></name></person-group><article-title>Current and emerging trends in point-of-care technology and strategies for clinical validation and implementation</article-title><source>Clin Chem</source><year>2018</year><volume>64</volume><issue>10</issue><fpage>1439</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">29884677</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1373/clinchem.2018.287052</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Wang P, Kricka LJ. Current and emerging trends in point-of-care technology and strategies for clinical validation and implementation. Clin Chem. 2018;64(10):1439&#8211;52.<pub-id pub-id-type="pmid">29884677</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1373/clinchem.2018.287052</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><collab>EUROSURVEILLANCE EDITORIAL TEAM</collab></person-group><article-title>Call for papers for a special issue on how point of care/point of impact testing (POCT/ POIT) and self-testing impact surveillance and public health</article-title><source>Euro Surveillance: Bull Europeen Sur Les Maladies Transmissibles = Eur Commun Disease Bull</source><year>2019</year><volume>24</volume><issue>8</issue><fpage>1902213</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.2807/1560-7917.ES.2019.24.8.1902213</pub-id><pub-id pub-id-type="pmcid">PMC6446952</pub-id><pub-id pub-id-type="pmid">30808437</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">EUROSURVEILLANCE EDITORIAL TEAM. Call for papers for a special issue on how point of care/point of impact testing (POCT/ POIT) and self-testing impact surveillance and public health. Euro Surveillance: Bull Europeen Sur Les Maladies Transmissibles = Eur Commun Disease Bull. 2019;24(8): 1902213.<pub-id pub-id-type="doi" assigning-authority="pmc">10.2807/1560-7917.ES.2019.24.8.1902213</pub-id><pub-id pub-id-type="pmcid">PMC6446952</pub-id><pub-id pub-id-type="pmid">30808437</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>LEE V B C, MOHD-NAIM N F</surname><given-names>TAMIYAE</given-names></name><etal/></person-group><article-title>Trends in Paper-based electrochemical biosensors: from design to Application[J]</article-title><source>Anal Sciences: Int J Japan Soc Anal Chem</source><year>2018</year><volume>34</volume><issue>1</issue><fpage>7</fpage><lpage>18</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.2116/analsci.34.7</pub-id><pub-id pub-id-type="pmid">29321461</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">LEE V B C, MOHD-NAIM N F TAMIYAE, et al. Trends in Paper-based electrochemical biosensors: from design to Application[J]. Anal Sciences: Int J Japan Soc Anal Chem. 2018;34(1):7&#8211;18.<pub-id pub-id-type="doi" assigning-authority="pmc">10.2116/analsci.34.7</pub-id><pub-id pub-id-type="pmid">29321461</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Manz</surname><given-names>A</given-names></name><name name-style="western"><surname>Graber</surname><given-names>N</given-names></name><name name-style="western"><surname>Widmer</surname><given-names>HM</given-names></name></person-group><article-title>Miniaturized total chemical analysis systems: a novel concept for chemical sensing</article-title><source>Sensors and Actuators B: Chemical</source><year>1990</year><volume>1</volume><issue>1/6</issue><fpage>244</fpage><lpage>8</lpage></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Manz A, Graber N, Widmer HM. Miniaturized total chemical analysis systems: a novel concept for chemical sensing. Sensors and Actuators B: Chemical. 1990;1(1/6):244&#8211;8.</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhuang</surname><given-names>J</given-names></name><name name-style="western"><surname>Yin</surname><given-names>J</given-names></name><name name-style="western"><surname>Lv</surname><given-names>S</given-names></name><etal/></person-group><article-title>Advanced lab-on-a-chip to detect viruses - current challenges and future perspectives</article-title><source>Biosens Bioelectron</source><year>2020</year><volume>163</volume><fpage>112291</fpage><pub-id pub-id-type="pmid">32421630</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bios.2020.112291</pub-id><pub-id pub-id-type="pmcid">PMC7215165</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Zhuang J, Yin J, Lv S, et al. Advanced lab-on-a-chip to detect viruses - current challenges and future perspectives. Biosens Bioelectron. 2020;163: 112291.<pub-id pub-id-type="pmid">32421630</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bios.2020.112291</pub-id><pub-id pub-id-type="pmcid">PMC7215165</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nosrati</surname><given-names>R</given-names></name></person-group><article-title>Lab on a chip devices for fertility: from proof-of-concept to clinical impact</article-title><source>Lab Chip</source><year>2022</year><volume>22</volume><issue>9</issue><fpage>1680</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">35417508</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1039/d1lc01144h</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Nosrati R. Lab on a chip devices for fertility: from proof-of-concept to clinical impact. Lab Chip. 2022;22(9):1680&#8211;9.<pub-id pub-id-type="pmid">35417508</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1039/d1lc01144h</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DKHAR</surname><given-names>DS</given-names></name><name name-style="western"><surname>KUMARI</surname><given-names>R</given-names></name><name name-style="western"><surname>MALODE</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>Integrated lab-on-a-chip devices: fabrication methodologies, transduction system for sensing purposes[J]</article-title><source>J Pharm Biomed Anal</source><year>2023</year><volume>223</volume><fpage>115120</fpage><pub-id pub-id-type="pmid">36343538</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jpba.2022.115120</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">DKHAR DS, KUMARI R, MALODE SJ, et al. Integrated lab-on-a-chip devices: fabrication methodologies, transduction system for sensing purposes[J]. J Pharm Biomed Anal. 2023;223:115120.<pub-id pub-id-type="pmid">36343538</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jpba.2022.115120</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>LIU</surname><given-names>Y</given-names></name><name name-style="western"><surname>LU</surname><given-names>S</given-names></name><name name-style="western"><surname>ZHANG</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Printable biosensors towards next-generation point-of-care testing: paper substrate as an example[J]</article-title><source>Lab Chip</source><year>2023</year><volume>23</volume><issue>15</issue><fpage>3328</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">37439827</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1039/d3lc00038a</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">LIU Y, LU S, ZHANG Z, et al. Printable biosensors towards next-generation point-of-care testing: paper substrate as an example[J]. Lab Chip. 2023;23(15):3328&#8211;52.<pub-id pub-id-type="pmid">37439827</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1039/d3lc00038a</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Rong</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ma</surname><given-names>T</given-names></name><etal/></person-group><article-title>Photoelectrochemical sensors based on paper and their emerging applications in point-of-care testing</article-title><source>Biosens Bioelectron.</source><year>2023</year><volume>236</volume><fpage>115400</fpage><pub-id pub-id-type="pmid">37271095</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bios.2023.115400</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Wang Y, Rong Y, Ma T, et al. Photoelectrochemical sensors based on paper and their emerging applications in point-of-care testing. Biosens Bioelectron. 2023;236:115400.<pub-id pub-id-type="pmid">37271095</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bios.2023.115400</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gradisteanu Pircalabioru</surname><given-names>G</given-names></name><name name-style="western"><surname>Raileanu</surname><given-names>M</given-names></name></person-group><article-title>Fast detection of bacterial gut pathogens on miniaturized devices: an overview</article-title><source>Expert Rev Mol Diagn</source><year>2024</year><volume>24</volume><issue>3</issue><fpage>201</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">38347807</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/14737159.2024.2316756</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Gradisteanu Pircalabioru G, Raileanu M. Fast detection of bacterial gut pathogens on miniaturized devices: an overview. Expert Rev Mol Diagn. 2024;24(3):201&#8211;18.<pub-id pub-id-type="pmid">38347807</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/14737159.2024.2316756</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>KARBAKHSH RAVARI A, PINEDA-GALVAN Y, HUYNH</surname><given-names>A</given-names></name><etal/></person-group><article-title>Facile Light-Induced transformation of [RuII(bpy)2(bpyNO)]2&#8201;+&#8201;to [RuII(bpy)3]2[J]</article-title><source>Inorg Chem</source><year>2020</year><volume>59</volume><issue>19</issue><fpage>13880</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">32924462</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.inorgchem.0c01446</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">KARBAKHSH RAVARI A, PINEDA-GALVAN Y, HUYNH A, et al. Facile Light-Induced transformation of [RuII(bpy)2(bpyNO)]2&#8201;+&#8201;to [RuII(bpy)3]2[J]. Inorg Chem. 2020;59(19):13880&#8211;7.<pub-id pub-id-type="pmid">32924462</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.inorgchem.0c01446</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Giagu</surname><given-names>G</given-names></name><name name-style="western"><surname>Fracassa</surname><given-names>A</given-names></name><name name-style="western"><surname>Fiorani</surname><given-names>A</given-names></name><etal/></person-group><article-title>From theory to practice: understanding the challenges in the implementation of electrogenerated chemiluminescence for analytical applications</article-title><source>Mikrochim Acta</source><year>2024</year><volume>191</volume><issue>6</issue><fpage>359</fpage><pub-id pub-id-type="pmid">38819653</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00604-024-06413-1</pub-id><pub-id pub-id-type="pmcid">PMC11143011</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Giagu G, Fracassa A, Fiorani A, et al. From theory to practice: understanding the challenges in the implementation of electrogenerated chemiluminescence for analytical applications. Mikrochim Acta. 2024;191(6): 359.<pub-id pub-id-type="pmid">38819653</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00604-024-06413-1</pub-id><pub-id pub-id-type="pmcid">PMC11143011</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>P</given-names></name><name name-style="western"><surname>Meng</surname><given-names>H</given-names></name><name name-style="western"><surname>Han</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Determination of ascorbic acid using electrochemiluminescence sensor based on nitrogen and sulfur doping graphene quantum dots with luminol as internal standard</article-title><source>Mikrochim Acta</source><year>2021</year><volume>188</volume><issue>4</issue><fpage>120</fpage><pub-id pub-id-type="pmid">33694007</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00604-021-04761-w</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Liu P, Meng H, Han Q, et al. Determination of ascorbic acid using electrochemiluminescence sensor based on nitrogen and sulfur doping graphene quantum dots with luminol as internal standard. Mikrochim Acta. 2021;188(4): 120.<pub-id pub-id-type="pmid">33694007</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00604-021-04761-w</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>ZHOU</surname><given-names>X</given-names></name><name name-style="western"><surname>ZHU</surname><given-names>D</given-names></name><name name-style="western"><surname>LIAO</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Synthesis, labeling and bioanalytical applications of a tris(2,2&#8217;-bipyridyl)ruthenium(II)-based electrochemiluminescence probe[J]</article-title><source>Nat Protoc</source><year>2014</year><volume>9</volume><issue>5</issue><fpage>1146</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">24743421</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nprot.2014.060</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">ZHOU X, ZHU D, LIAO Y, et al. Synthesis, labeling and bioanalytical applications of a tris(2,2&#8217;-bipyridyl)ruthenium(II)-based electrochemiluminescence probe[J]. Nat Protoc. 2014;9(5):1146&#8211;59.<pub-id pub-id-type="pmid">24743421</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nprot.2014.060</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guan</surname><given-names>W</given-names></name><name name-style="western"><surname>Liu</surname><given-names>M</given-names></name></person-group><article-title>Electrochemiluminescence detection in microfluidic cloth-based analytical devices</article-title><source>Biosens Bioelectron</source><year>2016</year><volume>75</volume><fpage>247</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">26319168</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bios.2015.08.023</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Guan W, Liu M. Electrochemiluminescence detection in microfluidic cloth-based analytical devices. Biosens Bioelectron. 2016;75:247&#8211;53.<pub-id pub-id-type="pmid">26319168</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bios.2015.08.023</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kitte</surname><given-names>SA</given-names></name><name name-style="western"><surname>Bushira</surname><given-names>FA</given-names></name><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><etal/></person-group><article-title>Electrochemiluminescence of Ru(bpy)32+/thioacetamide and its application for the sensitive determination of hepatotoxic thioacetamide</article-title><source>Analyst</source><year>2021</year><volume>146</volume><issue>16</issue><fpage>5198</fpage><lpage>203</lpage><pub-id pub-id-type="pmid">34308456</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1039/d1an00862e</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Kitte SA, Bushira FA, Li H, et al. Electrochemiluminescence of Ru(bpy)32+/thioacetamide and its application for the sensitive determination of hepatotoxic thioacetamide. Analyst. 2021;146(16):5198&#8211;203.<pub-id pub-id-type="pmid">34308456</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1039/d1an00862e</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name></person-group><article-title>Advances in electrochemiluminescence co-reaction accelerator and its analytical applications</article-title><source>Anal Bioanal Chem</source><year>2021</year><volume>413</volume><issue>16</issue><fpage>4119</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">33715042</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00216-021-03247-1</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Wang H. Advances in electrochemiluminescence co-reaction accelerator and its analytical applications. Anal Bioanal Chem. 2021;413(16):4119&#8211;35.<pub-id pub-id-type="pmid">33715042</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00216-021-03247-1</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>He</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>J</given-names></name><etal/></person-group><article-title>Hydrophobic localized enrichment of co-reactants to enhance electrochemiluminescence of conjugated polymers for detecting SARS-CoV-2 nucleocapsid proteins</article-title><source>Anal Chem</source><year>2022</year><volume>94</volume><issue>10</issue><fpage>4446</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">35230820</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.analchem.1c05407</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Chen Y, He Y, Zhao J, et al. Hydrophobic localized enrichment of co-reactants to enhance electrochemiluminescence of conjugated polymers for detecting SARS-CoV-2 nucleocapsid proteins. Anal Chem. 2022;94(10):4446&#8211;54.<pub-id pub-id-type="pmid">35230820</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.analchem.1c05407</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>L</given-names></name><name name-style="western"><surname>Wu</surname><given-names>D</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>R</given-names></name><etal/></person-group><article-title>Novel cathodic and anodic dual-emitting electrochemiluminescence of Ru(bpy)32+/&#945;-keto acid system</article-title><source>Mikrochim Acta</source><year>2024</year><volume>191</volume><issue>8</issue><fpage>486</fpage><pub-id pub-id-type="pmid">39060485</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00604-024-06554-3</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Ma L, Wu D, Xiao R, et al. Novel cathodic and anodic dual-emitting electrochemiluminescence of Ru(bpy)32+/&#945;-keto acid system. Mikrochim Acta. 2024;191(8): 486.<pub-id pub-id-type="pmid">39060485</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00604-024-06554-3</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zheng</surname><given-names>G</given-names></name><name name-style="western"><surname>Hu</surname><given-names>S</given-names></name></person-group><article-title>Aggregation-induced electrochemiluminescence enhancement of Ag-MOG for amyloid &#946; 42 sensing</article-title><source>Anal Chim Acta</source><year>2023</year><volume>1281</volume><fpage>341898</fpage><pub-id pub-id-type="pmid">38783738</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.aca.2023.341898</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Zheng G, Hu S. Aggregation-induced electrochemiluminescence enhancement of Ag-MOG for amyloid &#946; 42 sensing. Anal Chim Acta. 2023;1281: 341898.<pub-id pub-id-type="pmid">38783738</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.aca.2023.341898</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>X</given-names></name><name name-style="western"><surname>Kang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Li</surname><given-names>M</given-names></name><etal/></person-group><article-title>Sensitive, signal-modulation strategy for discrimination of ECL spectra and investigation of mutual interactions of emitters[J]</article-title><source>Anal Chem</source><year>2022</year><volume>94</volume><issue>8</issue><fpage>3637</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">35187927</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.analchem.1c05217</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Ma X, Kang Q, Li M, et al. Sensitive, signal-modulation strategy for discrimination of ECL spectra and investigation of mutual interactions of emitters[J]. Anal Chem. 2022;94(8):3637&#8211;44.<pub-id pub-id-type="pmid">35187927</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.analchem.1c05217</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><name name-style="western"><surname>Yang</surname><given-names>L</given-names></name><name name-style="western"><surname>Li</surname><given-names>S</given-names></name><etal/></person-group><article-title>Near-infrared electrochemiluminescence biosensors facilitated by thermally activated delayed fluorescence (TADF) emitters for ctdna analysis</article-title><source>Biosens Bioelectron</source><year>2024</year><volume>251</volume><fpage>116103</fpage><pub-id pub-id-type="pmid">38382269</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bios.2024.116103</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Liu J, Yang L, Li S, et al. Near-infrared electrochemiluminescence biosensors facilitated by thermally activated delayed fluorescence (TADF) emitters for ctdna analysis. Biosens Bioelectron. 2024;251: 116103.<pub-id pub-id-type="pmid">38382269</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bios.2024.116103</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>HAN</surname><given-names>D</given-names></name><name name-style="western"><surname>GOUDEAU</surname><given-names>B</given-names></name><name name-style="western"><surname>JIANG</surname><given-names>D</given-names></name><etal/></person-group><article-title>Electrochemiluminescence microscopy of cells: essential role of surface Regeneration[J]</article-title><source>Anal Chem</source><year>2021</year><volume>93</volume><issue>3</issue><fpage>1652</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">33375779</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.analchem.0c05123</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">HAN D, GOUDEAU B, JIANG D, et al. Electrochemiluminescence microscopy of cells: essential role of surface Regeneration[J]. Anal Chem. 2021;93(3):1652&#8211;7.<pub-id pub-id-type="pmid">33375779</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.analchem.0c05123</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>F</given-names></name><name name-style="western"><surname>You</surname><given-names>M</given-names></name><name name-style="western"><surname>Li</surname><given-names>S</given-names></name><etal/></person-group><article-title>Paper-based point-of-care immunoassays: recent advances and emerging trends</article-title><source>Biotechnol Adv</source><year>2020</year><volume>39</volume><fpage>107442</fpage><pub-id pub-id-type="pmid">31470046</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biotechadv.2019.107442</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Li F, You M, Li S, et al. Paper-based point-of-care immunoassays: recent advances and emerging trends. Biotechnol Adv. 2020;39: 107442.<pub-id pub-id-type="pmid">31470046</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biotechadv.2019.107442</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>R</given-names></name><name name-style="western"><surname>Li</surname><given-names>M</given-names></name><name name-style="western"><surname>Yan</surname><given-names>X</given-names></name><etal/></person-group><article-title>Comparison of paper-based nucleic acid extraction materials for point-of-care testing applications</article-title><source>Cellulose</source><year>2022</year><volume>29</volume><issue>4</issue><fpage>2479</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">35125684</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10570-022-04444-6</pub-id><pub-id pub-id-type="pmcid">PMC8799969</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Tang R, Li M, Yan X, et al. Comparison of paper-based nucleic acid extraction materials for point-of-care testing applications. Cellulose. 2022;29(4):2479&#8211;95.<pub-id pub-id-type="pmid">35125684</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10570-022-04444-6</pub-id><pub-id pub-id-type="pmcid">PMC8799969</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="other">Sonagra AD, Dholariya SJ. Electrophoresis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. PMID: 36251838.<pub-id pub-id-type="pmid">36251838</pub-id></mixed-citation></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khatmi</surname><given-names>G</given-names></name><name name-style="western"><surname>Klinavi&#269;ius</surname><given-names>T</given-names></name><name name-style="western"><surname>Simanavi&#269;ius</surname><given-names>M</given-names></name><etal/></person-group><article-title>Lateral flow assay sensitivity and signal enhancement via laser &#181;-machined constrains in nitrocellulose membrane</article-title><source>Sci Rep</source><year>2024</year><volume>14</volume><issue>1</issue><fpage>22936</fpage><pub-id pub-id-type="pmid">39358489</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-024-74407-3</pub-id><pub-id pub-id-type="pmcid">PMC11446913</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Khatmi G, Klinavi&#269;ius T, Simanavi&#269;ius M, et al. Lateral flow assay sensitivity and signal enhancement via laser &#181;-machined constrains in nitrocellulose membrane. Sci Rep. 2024;14(1): 22936.<pub-id pub-id-type="pmid">39358489</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-024-74407-3</pub-id><pub-id pub-id-type="pmcid">PMC11446913</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hoffman</surname><given-names>ER</given-names></name><name name-style="western"><surname>Rangaswamy</surname><given-names>AMM</given-names></name><name name-style="western"><surname>Cleveland</surname><given-names>ME</given-names></name><etal/></person-group><article-title>Targeted Genome Mining Facilitates the Discovery of a Promiscuous, Hyperthermostable Amidase from Thermovenabulum Gondwanense with Notable Nylon-Degrading Capacity</article-title><source>Angew Chem Int Ed Engl.</source><year>2025</year><volume>64</volume><issue>2</issue><fpage>e202414842</fpage><pub-id pub-id-type="pmid">39441552</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/anie.202414842</pub-id><pub-id pub-id-type="pmcid">PMC11720373</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">Hoffman ER, Rangaswamy AMM, Cleveland ME, et al. Targeted Genome Mining Facilitates the Discovery of a Promiscuous, Hyperthermostable Amidase from Thermovenabulum Gondwanense with Notable Nylon-Degrading Capacity. Angew Chem Int Ed Engl. 2025;64(2):e202414842.<pub-id pub-id-type="pmid">39441552</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/anie.202414842</pub-id><pub-id pub-id-type="pmcid">PMC11720373</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nualnoi</surname><given-names>T</given-names></name><name name-style="western"><surname>Wongwitwichot</surname><given-names>P</given-names></name></person-group><article-title>Development of an antigen capture lateral flow immunoassay for the detection of <italic toggle="yes">Burkholderia pseudomallei</italic></article-title><source>Diagnostics</source><year>2024</year><volume>14</volume><issue>10</issue><fpage>1033</fpage><pub-id pub-id-type="pmid">38786331</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/diagnostics14101033</pub-id><pub-id pub-id-type="pmcid">PMC11120185</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Nualnoi T, Wongwitwichot P. Development of an antigen capture lateral flow immunoassay for the detection of <italic toggle="yes">Burkholderia pseudomallei</italic>. Diagnostics. 2024;14(10): 1033.<pub-id pub-id-type="pmid">38786331</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/diagnostics14101033</pub-id><pub-id pub-id-type="pmcid">PMC11120185</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Benirschke</surname><given-names>RC</given-names></name><name name-style="western"><surname>Lee</surname><given-names>HK</given-names></name></person-group><article-title>Hook effect in semiquantitative SARS-CoV-2 antispike total antibody assay</article-title><source>Am J Clin Pathol</source><year>2023</year><volume>160</volume><issue>3</issue><fpage>225</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">37202900</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ajcp/aqad043</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Benirschke RC, Lee HK. Hook effect in semiquantitative SARS-CoV-2 antispike total antibody assay. Am J Clin Pathol. 2023;160(3):225&#8211;8.<pub-id pub-id-type="pmid">37202900</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ajcp/aqad043</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Espino</surname><given-names>AM</given-names></name><name name-style="western"><surname>Armina-Rodriguez</surname><given-names>A</given-names></name><name name-style="western"><surname>Cardona</surname><given-names>P</given-names></name><etal/></person-group><article-title>Anti-SARS-CoV-2 IgM antibody levels measured by an in-house ELISA in a convalescent Latin population persist over time and exhibit neutralizing capacity to several variants of concern</article-title><source>Diagnostics</source><year>2024</year><volume>14</volume><issue>19</issue><fpage>2209</fpage><pub-id pub-id-type="pmid">39410613</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/diagnostics14192209</pub-id><pub-id pub-id-type="pmcid">PMC11475847</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Espino AM, Armina-Rodriguez A, Cardona P, et al. Anti-SARS-CoV-2 IgM antibody levels measured by an in-house ELISA in a convalescent Latin population persist over time and exhibit neutralizing capacity to several variants of concern. Diagnostics. 2024;14(19): 2209.<pub-id pub-id-type="pmid">39410613</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/diagnostics14192209</pub-id><pub-id pub-id-type="pmcid">PMC11475847</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jampasa</surname><given-names>S</given-names></name><name name-style="western"><surname>Sangthong</surname><given-names>N</given-names></name><name name-style="western"><surname>Ozer</surname><given-names>T</given-names></name><etal/></person-group><article-title>Label-free electrochemical aptasensor based on cellulose nanocrystal-modified paper-based device for <italic toggle="yes">Salmonella typhimurium</italic> detection in food samples</article-title><source>Microchem J</source><year>2025</year><volume>211</volume><fpage>113144</fpage></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Jampasa S, Sangthong N, Ozer T, et al. Label-free electrochemical aptasensor based on cellulose nanocrystal-modified paper-based device for <italic toggle="yes">Salmonella typhimurium</italic> detection in food samples. Microchem J. 2025;211: 113144.</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mandrekar</surname><given-names>JN</given-names></name></person-group><article-title>Measures of interrater agreement</article-title><source>J Thorac Oncol</source><year>2011</year><volume>6</volume><issue>1</issue><fpage>6</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">21178713</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/JTO.0b013e318200f983</pub-id></element-citation><mixed-citation id="mc-CR34" publication-type="journal">Mandrekar JN. Measures of interrater agreement. J Thorac Oncol. 2011;6(1):6&#8211;7.<pub-id pub-id-type="pmid">21178713</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/JTO.0b013e318200f983</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Azkur</surname><given-names>AK</given-names></name><name name-style="western"><surname>Akdis</surname><given-names>M</given-names></name></person-group><article-title>Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19</article-title><source>Allergy</source><year>2020</year><volume>75</volume><issue>7</issue><fpage>1564</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">32396996</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/all.14364</pub-id><pub-id pub-id-type="pmcid">PMC7272948</pub-id></element-citation><mixed-citation id="mc-CR35" publication-type="journal">Azkur AK, Akdis M. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy. 2020;75(7):1564&#8211;81.<pub-id pub-id-type="pmid">32396996</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/all.14364</pub-id><pub-id pub-id-type="pmcid">PMC7272948</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alafeef</surname><given-names>M</given-names></name></person-group><article-title>Diagnostic approaches for COVID-19: lessons learned and the path forward</article-title><source>ACS Nano</source><year>2022</year><volume>16</volume><issue>8</issue><fpage>11545</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">35921264</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acsnano.2c01697</pub-id></element-citation><mixed-citation id="mc-CR36" publication-type="journal">Alafeef M. Diagnostic approaches for COVID-19: lessons learned and the path forward. ACS Nano. 2022;16(8):11545&#8211;76.<pub-id pub-id-type="pmid">35921264</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acsnano.2c01697</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deenin</surname><given-names>W</given-names></name><name name-style="western"><surname>Yakoh</surname><given-names>A</given-names></name><name name-style="western"><surname>Pimpitak</surname><given-names>U</given-names></name><etal/></person-group><article-title>Electrochemical lateral-flow device for rapid COVID-19 antigen-diagnostic testing</article-title><source>Bioelectrochemistry.</source><year>2023</year><volume>152</volume><fpage>108438</fpage><pub-id pub-id-type="pmid">37054603</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bioelechem.2023.108438</pub-id><pub-id pub-id-type="pmcid">PMC10077809</pub-id></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Deenin W, Yakoh A, Pimpitak U, et al. Electrochemical lateral-flow device for rapid COVID-19 antigen-diagnostic testing. Bioelectrochemistry. 2023;152:108438.<pub-id pub-id-type="pmid">37054603</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bioelechem.2023.108438</pub-id><pub-id pub-id-type="pmcid">PMC10077809</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>WANG</surname><given-names>AR</given-names></name><name name-style="western"><surname>WANG</surname><given-names>H</given-names></name></person-group><article-title>Summary of the detection kits for SARS-CoV-2 approved by the National medical products administration of China and their application for diagnosis of COVID-19[J]</article-title><source>Virol Sin</source><year>2020</year><volume>35</volume><issue>6</issue><fpage>699</fpage><lpage>712</lpage><pub-id pub-id-type="pmid">33351166</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12250-020-00331-1</pub-id><pub-id pub-id-type="pmcid">PMC7754703</pub-id></element-citation><mixed-citation id="mc-CR38" publication-type="journal">WANG AR, WANG H. Summary of the detection kits for SARS-CoV-2 approved by the National medical products administration of China and their application for diagnosis of COVID-19[J]. Virol Sin. 2020;35(6):699&#8211;712.<pub-id pub-id-type="pmid">33351166</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12250-020-00331-1</pub-id><pub-id pub-id-type="pmcid">PMC7754703</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>C</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>L</given-names></name><name name-style="western"><surname>Du</surname><given-names>K</given-names></name><etal/></person-group><article-title>Foundation and clinical evaluation of a new method for detecting SARS-CoV-2 antigen by fluorescent microsphere immunochromatography</article-title><source>Front Cell Infect Microbiol</source><year>2020</year><volume>10</volume><fpage>553837</fpage><pub-id pub-id-type="pmid">33330119</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fcimb.2020.553837</pub-id><pub-id pub-id-type="pmcid">PMC7734310</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Zhang C, Zhou L, Du K, et al. Foundation and clinical evaluation of a new method for detecting SARS-CoV-2 antigen by fluorescent microsphere immunochromatography. Front Cell Infect Microbiol. 2020;10: 553837.<pub-id pub-id-type="pmid">33330119</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fcimb.2020.553837</pub-id><pub-id pub-id-type="pmcid">PMC7734310</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>LIPPI</surname><given-names>G</given-names></name><name name-style="western"><surname>HENRY B M</surname><given-names>PLEBANIM</given-names></name></person-group><article-title>An overview of the most important preanalytical factors influencing the clinical performance of SARS-CoV-2 antigen rapid diagnostic tests (Ag-RDTs)[J]</article-title><source>Clin Chem Lab Med</source><year>2023</year><volume>61</volume><issue>2</issue><fpage>196</fpage><lpage>204</lpage><pub-id pub-id-type="pmid">36343376</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1515/cclm-2022-1058</pub-id></element-citation><mixed-citation id="mc-CR40" publication-type="journal">LIPPI G, HENRY B M PLEBANIM. An overview of the most important preanalytical factors influencing the clinical performance of SARS-CoV-2 antigen rapid diagnostic tests (Ag-RDTs)[J]. Clin Chem Lab Med. 2023;61(2):196&#8211;204.<pub-id pub-id-type="pmid">36343376</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1515/cclm-2022-1058</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Slomovic</surname><given-names>S</given-names></name><name name-style="western"><surname>Pardee</surname><given-names>K</given-names></name><name name-style="western"><surname>Collins</surname><given-names>JJ</given-names></name></person-group><article-title>Synthetic biology devices for <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic> diagnostics</article-title><source>Proc Natl Acad Sci U S A</source><year>2015</year><volume>112</volume><issue>47</issue><fpage>14429</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">26598662</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1508521112</pub-id><pub-id pub-id-type="pmcid">PMC4664311</pub-id></element-citation><mixed-citation id="mc-CR41" publication-type="journal">Slomovic S, Pardee K, Collins JJ. Synthetic biology devices for <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic> diagnostics. Proc Natl Acad Sci U S A. 2015;112(47):14429&#8211;35.<pub-id pub-id-type="pmid">26598662</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1508521112</pub-id><pub-id pub-id-type="pmcid">PMC4664311</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rahman</surname><given-names>A</given-names></name><name name-style="western"><surname>Kang</surname><given-names>S</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name><etal/></person-group><article-title>Nanobiotechnology enabled approaches for wastewater based epidemiology</article-title><source>TrAC Trends Anal Chem</source><year>2021</year><volume>143</volume><fpage>116400</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.trac.2021.116400</pub-id><pub-id pub-id-type="pmcid">PMC8317456</pub-id><pub-id pub-id-type="pmid">34334850</pub-id></element-citation><mixed-citation id="mc-CR42" publication-type="journal">Rahman A, Kang S, Wang W, et al. Nanobiotechnology enabled approaches for wastewater based epidemiology. TrAC Trends Anal Chem. 2021;143: 116400.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.trac.2021.116400</pub-id><pub-id pub-id-type="pmcid">PMC8317456</pub-id><pub-id pub-id-type="pmid">34334850</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Satta</surname><given-names>S</given-names></name><name name-style="western"><surname>Shahabipour</surname><given-names>F</given-names></name><name name-style="western"><surname>Gao</surname><given-names>W</given-names></name><etal/></person-group><article-title>Engineering viral genomics and nano-liposomes in microfluidic platforms for patient-specific analysis of SARS-CoV-2 variants</article-title><source>Theranostics</source><year>2022</year><volume>12</volume><issue>10</issue><fpage>4779</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">35832078</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7150/thno.72339</pub-id><pub-id pub-id-type="pmcid">PMC9254234</pub-id></element-citation><mixed-citation id="mc-CR43" publication-type="journal">Satta S, Shahabipour F, Gao W, et al. Engineering viral genomics and nano-liposomes in microfluidic platforms for patient-specific analysis of SARS-CoV-2 variants. Theranostics. 2022;12(10):4779&#8211;90.<pub-id pub-id-type="pmid">35832078</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7150/thno.72339</pub-id><pub-id pub-id-type="pmcid">PMC9254234</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dorta-Gorr&#237;n</surname><given-names>A</given-names></name><name name-style="western"><surname>Navas-M&#233;ndez</surname><given-names>J</given-names></name><name name-style="western"><surname>Gozalo-Marg&#252;ello</surname><given-names>M</given-names></name><etal/></person-group><article-title>Detection of SARS-CoV-2 based on nucleic acid amplification tests (NAATs) and its integration into nanomedicine and microfluidic devices as point-of-care testing (POCT)</article-title><source>Int J Mol Sci</source><year>2023</year><volume>24</volume><issue>12</issue><fpage>10233</fpage><pub-id pub-id-type="pmid">37373381</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms241210233</pub-id><pub-id pub-id-type="pmcid">PMC10299269</pub-id></element-citation><mixed-citation id="mc-CR44" publication-type="journal">Dorta-Gorr&#237;n A, Navas-M&#233;ndez J, Gozalo-Marg&#252;ello M, et al. Detection of SARS-CoV-2 based on nucleic acid amplification tests (NAATs) and its integration into nanomedicine and microfluidic devices as point-of-care testing (POCT). Int J Mol Sci. 2023;24(12): 10233.<pub-id pub-id-type="pmid">37373381</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms241210233</pub-id><pub-id pub-id-type="pmcid">PMC10299269</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chan</surname><given-names>YSCHAEM</given-names></name><etal/></person-group><article-title>Programmable digital-microfluidic biochips for SARS-CoV-2 detection</article-title><source>Bioengineering</source><year>2023</year><volume>10</volume><issue>8</issue><fpage>923</fpage><pub-id pub-id-type="pmid">37627808</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/bioengineering10080923</pub-id><pub-id pub-id-type="pmcid">PMC10451662</pub-id></element-citation><mixed-citation id="mc-CR45" publication-type="journal">Wang Y, Chan YSCHAEM, et al. Programmable digital-microfluidic biochips for SARS-CoV-2 detection. Bioengineering. 2023;10(8): 923.<pub-id pub-id-type="pmid">37627808</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/bioengineering10080923</pub-id><pub-id pub-id-type="pmcid">PMC10451662</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>RANJAN</surname><given-names>P</given-names></name><name name-style="western"><surname>SINGHAL</surname><given-names>A</given-names></name><name name-style="western"><surname>YADAV</surname><given-names>S</given-names></name><etal/></person-group><article-title>Rapid diagnosis of SARS-CoV-2 using potential point-of-care electrochemical immunosensor: toward the future prospects[J]</article-title><source>Int Rev Immunol</source><year>2021</year><volume>40</volume><issue>1&#8211;2</issue><fpage>126</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">33448909</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/08830185.2021.1872566</pub-id></element-citation><mixed-citation id="mc-CR46" publication-type="journal">RANJAN P, SINGHAL A, YADAV S, et al. Rapid diagnosis of SARS-CoV-2 using potential point-of-care electrochemical immunosensor: toward the future prospects[J]. Int Rev Immunol. 2021;40(1&#8211;2):126&#8211;42.<pub-id pub-id-type="pmid">33448909</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/08830185.2021.1872566</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Drobysh</surname><given-names>M</given-names></name><name name-style="western"><surname>Ramanaviciene</surname><given-names>A</given-names></name><name name-style="western"><surname>Viter</surname><given-names>R</given-names></name><etal/></person-group><article-title>Biosensors for the determination of SARS-CoV-2 virus and diagnosis of COVID-19 infection</article-title><source>Int J Mol Sci</source><year>2022</year><volume>23</volume><issue>2</issue><fpage>666</fpage><pub-id pub-id-type="pmid">35054850</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms23020666</pub-id><pub-id pub-id-type="pmcid">PMC8776074</pub-id></element-citation><mixed-citation id="mc-CR47" publication-type="journal">Drobysh M, Ramanaviciene A, Viter R, et al. Biosensors for the determination of SARS-CoV-2 virus and diagnosis of COVID-19 infection. Int J Mol Sci. 2022;23(2): 666.<pub-id pub-id-type="pmid">35054850</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms23020666</pub-id><pub-id pub-id-type="pmcid">PMC8776074</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>